Cytek Biosciences (CTKB) Other Operating Expenses (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Other Operating Expenses data on file, last reported at $11.6 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 6.9% year-over-year to $11.6 million; the trailing twelve-month figure through Mar 2026 stood at $48.6 million (down 1.02% YoY), and the FY2025 full-year result was $49.4 million, up 0.66% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $11.6 million, down from $13.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $13.1 million in Q4 2025 and bottomed at -$6.2 million in Q1 2023.
• The 5-year median for Other Operating Expenses is $11.7 million (2025), against an average of $8.0 million.
• The widest annual swing landed in 2023, when Other Operating Expenses plunged 226.69%; it then soared 375.31% in 2024.
• A 5-year view of Other Operating Expenses shows it stood at $9.0 million in 2022, then climbed by 28.04% to $11.6 million in 2023, then rose by 2.71% to $11.9 million in 2024, then increased by 10.59% to $13.1 million in 2025, then fell by 11.31% to $11.6 million in 2026.
• The last three Other Operating Expenses figures came in at $11.6 million (Q1 2026), $13.1 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.

Peer Comparison